Page 10 - Natasha Loder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Absolutely Maybe We’ve well and truly reached cherry-picking season on Covid vaccine data! It’s definitely easier to fall into the trap of claims based on a biased selection of information – and harder to keep up with developments. With over 1 billion doses of Covid vaccines injected globally, the amount of datasets and studies is vast. Fortunately, there are now well over half a million people in phase 3 trials for Covid vaccines, providing an important base of critical information. That number could get close to a million in the coming months. A big thank you to everyone participatin...

Application Deadline: June 4th 2021 The John Maddox prize is a joint initiative of the charity Sense about Science and the leading international scientific journal  Nature. The Prize has been awarded annually since 2012 to researchers who have shown great courage and integrity in standing up for science and scientific reasoning against fierce opposition and hostility. Each year there is one or two winners, and an additional prize for an early career researcher. The prize brings into the spotlight the difficulty faced by many who fight to share the results of research evidence, and inspires...

How understanding light has led to a hundred years of bright ideas The revolutionary theory of the nature of light which won Albert Einstein the 1921 Nobel prize for physics went on to remake the world. Oliver Morton surveys a century of innovation

MORE THAN a billion vaccines have been administered. But the contrast between Israel, largely free of covid-19, and India, struggling with a catastrophic second wave, is stark. What explains the discrepancy? Devi Sridhar, Founding Director of the Global Health Governance Programme, tells us what to expect as the next billion vaccines roll out. Alok Jha and Natasha Loder are joined by Slavea Chankova, The Economist’s health-care correspondent, and technology correspondent Hal Hodson. Anshel Pfeffer reports from Israel. Runtime: 38 min For full access to The Economist’s print, digital a...

WhatsApp ALL ADULTS in America are now eligible for a covid-19 vaccine. Around 30% of those polled in the country, however, are hesitant to take the jab. A shortage of vaccines will soon become a shortage of arms. What is the best way to persuade reluctant citizens to get inoculated? We speak to Heidi Larson, anthropologist at the London School of Hygiene and Tropical Medicine and founding director of the Vaccine Confidence Project, about the similarities between vaccine hesitancy today and the 19th century. Crystal Son, director of healthcare analytics at Civis Analytics, on why vaccine safe...